Table 4.
Five-year observed survival, 95% confdence intervals and log-rank p-values for prostate cancer by selected demographic characteristics, Oklahoma, 1997-2008, Oklahoma Central Cancer Registry
| American Indian/ Alaskan Native |
White | African American | |||||
|---|---|---|---|---|---|---|---|
| Observed Survival |
95% CI | Observed Survival |
95% CI | Observed Survival |
95% CI | p-value | |
| Years | |||||||
| 1997-2000 | 76.3 | (72.2, 79.8) | 75.2 | (74.2, 76.1) | 70.4 | (66.7, 73.8) | 0.0004 |
| 2001-2004 | 76.8 | (73.3, 79.9) | 77.3 | (76.4, 78.2) | 75.0 | (71.6, 78.1) | 0.16 |
| 2005-2008 | 79.8 | (76.4, 82.8) | 79.9 | (79.0, 80.8) | 79.5 | (76.4, 82.2) | 0.58 |
|
Age Group
(years) |
|||||||
| <40 | suppressed | 81.8 | (44.7, 95.1) | 100.0 | 0.40 | ||
| 40-49 | 86.7 | (68.3, 94.8) | 93.4 | (90.7, 95.4) | 96.8 | (90.4, 99.0) | 0.29 |
| 50-59 | 88.2 | (84.1, 91.4) | 92.6 | (91.7, 93.4) | 88.9 | (85.7, 91.5) | <0.0001 |
| 60-69 | 87.1 | (84.3, 89.4) | 87.4 | (86.7, 88.1) | 81.6 | (78.6, 84.2) | <0.0001 |
| ≥70 | 64.8 | (61.2, 68.1) | 65.6 | (64.7, 66.5) | 58.5 | (55.0, 61.9) | <0.0001 |
|
Rural/Urban
Continuum |
|||||||
| Metropolitan | 80.1 | (77.0, 82.8) | 79.4 | (78.7, 80.0) | 76.6 | (74.4, 78.6) | 0.003 |
| Non- Metropolitan |
76.0 | (73.2, 78.5) | 75.0 | (74.1, 75.8) | 70.2 | (65.7, 74.3) | 0.07 |
| Marital Status | |||||||
| Married | 83.2 | (80.7, 85.4) | 82.5 | (81.9, 83.0) | 82.4 | (80.1, 84.5) | 0.49 |
| Single | 78.3 | (72.8, 82.9) | 74.5 | (72.6, 76.3) | 74.5 | (70.2, 78.4) | 0.73 |
| Unknown | 65.9 | (61.4, 70.0) | 63.4 | (62.1, 64.7) | 58.1 | (53.6, 62.4) | 0.004 |
| Primary Payer | |||||||
| Uninsured | 63.2 | (49.3, 74.2) | 55.3 | (51.9, 58.6) | 54.3 | (43.7, 63.7) | 0.25 |
| Insured | 89.6 | (86.0, 92.2) | 90.9 | (90.1, 91.5) | 90.6 | (88.0, 92.6) | 0.02 |
| Medicaid | 52.0 | (37.4, 64.7) | 58.4 | (52.5, 63.8) | 64.1 | (53.4, 73.0) | 0.50 |
| Medicare | 73.4 | (70.3, 76.2) | 73.4 | (72.7, 74.2) | 68.8 | (65.4, 71.8) | 0.007 |
| Medicare/ Medicaid |
78.6 | (58.4, 89.8) | 62.5 | (54.3, 69.7) | 71.8 | (54.9, 83.3) | 0.97 |
| VA/Tricare Military |
86.0 | (72.9, 93.1) | 81.6 | (78.7, 84.1) | 82.4 | (76.7, 86.8) | 0.83 |
| Indian Health Services |
86.8 | (80.2, 91.2) | 66.7 | (44.3, 81.7) | 85.7 | (33.4, 97.9) | 0.08 |
| Unknown | 74.3 | (66.9, 80.2) | 71.9 | (69.9, 73.8) | 58.4 | (50.7, 65.3) | <0.0001 |
| Stage | |||||||
| In Situ | suppressed | 81.3 | (52.5, 93.5) | suppressed | NA | ||
| Localized | 82.5 | (80.4, 84.5) | 83.1 | (82.5, 83.6) | 83.5 | (81.5, 85.2) | 0.05 |
| Regional | 79.6 | (72.4, 85.1) | 84.1 | (82.5, 85.6) | 88.8 | (82.9, 92.7) | 0.003 |
| Distant | 21.5 | (13.3, 31.1) | 23.0 | (20.4, 25.7) | 19.1 | (13.1, 26.0) | 0.46 |
| Unstaged | 66.3 | (59.0, 72.6) | 50.7 | (48.7, 52.7) | 40.9 | (34.2, 47.5) | <0.0001 |